TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Fibrin network permeability (K(s))
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improved self-esteem
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Improved parenting skills
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Improved communication with children
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Propofol dose requirement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Combined mortality/morbidity end point
Endpoint domain: Mortality/survival
Primary endpoint: Dissatisfaction with care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Psychosocial outcomes
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: fetal middle cerebral artery PI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Adherence behaviours
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Major cardiac and cerebrovascular events (MACCE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Ischemic stroke/systemic embolism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Structural remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in mTSS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical remission rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Insulin secretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Disposition index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Number of patients requiring rescue analgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CHIPPS score
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: heartburn score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: total percentage of time that pH was less than 4
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: medication use
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: BMD Z-scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Surgical site infections (SSIs)
Endpoint domain: Adverse events/effects
Primary endpoint: Plasma concentrations of epinephrine and cortisol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IFN‐gamma/IL‐10 ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Lymphocyte numbers and T‐helper cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Rate of change of normalized CBFV
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: episodes of microscopic hematuria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Urinary outcomes
Primary endpoint: catheter convenience score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: insertion comfort score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Composite of major complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: TFG 3 incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: MBG 3 incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: TMPG 3 incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Serum sclerostin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Dkk‐1 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Bone markers (procollagen type 1 N‐terminal propeptide, C‐terminal cross‐linking telopeptide of type 1 collagen, total serum alkaline phosphatase)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Improvements in S(I)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Reductions in by-products of fatty acid oxidation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Increases in glycine and proline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Pain-free status after analgesic injection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of impairment of normal daily activities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Need for further emergency visits or hospitalization
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: More serious asthma attacks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Medication use
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Health knowledge
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Access to health care
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Risk-taking behaviors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Body Fat Percentage (BFP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Appendicular Skeletal Muscle Mass (ASM/H2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MPO levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: ox-LDL levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: tumour necrosis rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: screening intentions
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: level of sedation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: root volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: amount of ERR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: prevalence of slanted RR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serum sFas‐L levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Differences in BMMD and 3D distances
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of developing type 2 diabetes
Endpoint domain: Mortality/survival
Primary endpoint: Mean prostatic tissue/plasma ulifloxacin concentration ratios
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative rejection free survival
Endpoint domain: Mortality/survival
Primary endpoint: Frequency of squamous skin tumors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Reduction in cutaneous dysplasia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Retching or vomiting
Endpoint domain: Adverse events/effects
Primary endpoint: Need for droperidol
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Sedentary time increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical activity time decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Activity recovery after hospitalization
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Total BADDS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Delayed paragraph recall
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: ASAS40 achievement at week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in inflammation in spine and sacroiliac joints
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prostate cancer screening knowledge
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Informed decision making
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Screening rates
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Need for major amputations
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Annual incidence of induced abortion
Endpoint domain: Mortality/survival
Primary endpoint: subject comfort
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percent decline in K(trans)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progression-free survival
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Development of ulcers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean daily glucose level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: incidence of total nosocomial infections
Endpoint domain: Adverse events/effects
Primary endpoint: incidence of hypoglycemia
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of post-procedure pancreatitis
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of severe hyperamylasemia
Endpoint domain: Adverse events/effects
Primary endpoint: Apparent diffusion coefficient (ADC) value
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Global opinion on the medication received
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Frequency and intensity of adverse effects
Endpoint domain: Adverse events/effects
Primary endpoint: Effectiveness in treating scalp seborrheic dermatitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of miconazole shampoo
Endpoint domain: Adverse events/effects
Primary endpoint: rehospitalization rate
Endpoint domain: Mortality/survival
Primary endpoint: serum T4 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: serum FT4 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: serum rT3 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Reduction of sensitivity of vital abutment teeth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceived attractiveness of a smile
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Incidence of diarrhea (G ≥ 2)
Endpoint domain: Adverse events/effects
Primary endpoint: Completion rate of S‐1 adjuvant chemotherapy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Duration of S‐1 adjuvant chemotherapy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Severity scores for allergic rhinitis symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional graft occlusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete graft occlusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall Constant score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: SKAMP-Combined scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CADS-P scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of bowel preparation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Symptom score of vomiting
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Cognitive decline prevention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Reduction in MCP contracture to less than 5°
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median VAS score for procedural pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Full extension of the treated MCP joint
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Referral rates to a pneumologist
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Confirmation rates of obstructive syndrome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Early COPD detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: I-QoL as a continence-specific measure of quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Allergenic activity reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: DBPCFC positivity
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency of uterine contractions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvements in running ability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: participation in the school environment
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Change in clinician-rated depression symptom scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of clinical estimates compared to sonographic estimates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean pulmonary wedge pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: total systemic resistance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 6-min walk test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: body mass index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: sit-ups
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 5-year survival estimates
Endpoint domain: Mortality/survival
Primary endpoint: Opioid use (morphine equivalents)
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Active range of motion (ROM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Need for assisted postoperative ventilation
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of postoperative medical complications
Endpoint domain: Adverse events/effects
Primary endpoint: T1 readings
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Energy Balance (EB)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: non-regional-recurrence survival rate
Endpoint domain: Mortality/survival
Primary endpoint: disease-free survival rate
Endpoint domain: Mortality/survival
Primary endpoint: grade 4 acute oral mucosa reaction
Endpoint domain: Adverse events/effects
Primary endpoint: ICM volume increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Total Functional Capacity (TFC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Trend toward decreased chorea
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Skill ratings using the Arizona Clinical Interview Rating Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in moderate-to-vigorous physical activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AD completion rates
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: IPV victimisation rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Receipt of IPV services
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: IPV self-efficacy
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Inter-rater agreement for fracture healing assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvements of knowledge
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: improvements of process
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Fibrinogen level decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Instances of fibrinogen level < 100 mg/dL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Development of thrombotic symptoms
Endpoint domain: Adverse events/effects
Primary endpoint: Weight management
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical cure rates for patients who switched
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion that actually switched to oral therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median time to actual switch therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of oral nystatin tablets
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Therapeutic response time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: average grade on the written examination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: having a screening mammogram
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: incidence of biopsy‐confirmed acute rejection
Endpoint domain: Adverse events/effects
Primary endpoint: Coronary Heart Disease (CHD) risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Stroke risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Total mortality risk
Endpoint domain: Mortality/survival
Primary endpoint: Corneal thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of cell loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Caesarean section rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Satisfaction with labour
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: increase in appropriate weight control strategies
Endpoint domain: Life impact
Endpoint subdomain: Behavioral functioning
Primary endpoint: Incidence of postoperative cognitive dysfunction 1 week after operation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage receiving HIV‐1 results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Death at <120 days of age
Endpoint domain: Mortality/survival
Primary endpoint: Need for ECMO
Endpoint domain: Mortality/survival
Primary endpoint: Mental demand
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Postural discomfort
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ability to brush and rinse
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Morning stiffness response rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neurological health of newborns
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Resumption of normal activities
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Satisfaction with outcome
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Per protocol eradication
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Per protocol ulcer healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Improvement on posttests and weekly measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of attacks of RP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of RP attacks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall disability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in mean urea concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in mean creatinine concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Functional parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EQ-5D health utility index scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Body fat percentage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: subjective satiety
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of bleeding days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of complete healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hypothermia incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes